The Acuscope was the first microcurrent modality when it was introduced in 1978. It is the only “intelligent” impedance-monitoring, biofeedback-regulated, microamperage therapeutic technology available today. As stated previously, the Acuscope and Myopulse can deliver precision waveforms (appropriate current formation) based on biofeedback from the tissue being assessed and treated. No other device on the market derives feedback (input) from the microelectricity of the human body’s nerves and muscles; no other equipment is programmed to calculate an individualized corrective (output) that safely and effectively restores cellular capacitance.  All other electrical stimulation devices are blind output only. There is no other microcurrent device that gives the operator feedback upon which to formulate a treatment plan or objectively track patient progress.